A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are either combined in ready form or mixed before administration. Safety, efficacy, and immunogenicity of a combined immunizing agent are high.
Based on vaccine type, the global human combination vaccines market can be segmented into inactivated vaccine and live attenuated vaccines. High acceptance of inactivated vaccine among physicians is attributed to strong growth of the segment. Moreover, inactivated vaccine is stable and can easily be stored and transported in freeze-dried form. In terms of end-user, the human combination vaccines market can be segmented into hospitals, clinics, and others. Hospitals is the leading segment of the market due to increase in government awareness and initiation of different programs for immunization against various diseases. Additionally, hospitals are preferred by both patients and physicians as these are modernized with all types of vaccines. According to the World Health Organization (WHO), vaccination has reduced the global weight of contagious ailment to a great extent. Low risk of side effects related to vaccines is leading to a positive response from numerous demographics and growing alertness regarding vaccination by several government and non-profit organizations are the key factors driving the human combination vaccines market. Vaccine manufacturers are working toward advancement of existing vaccines as well as development of novel vaccines. Moreover, combination vaccines reduce the cost of extra health care visits. However, manufacturers have to be encouraged to invest extensive capital and undergo rigorous regulatory approval processes for the development and approval of latest vaccines. Handling, storage, and transportation of vaccines incurs significant costs which can hamper the growth of the market.
In terms of geography, the global human combination vaccines market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa region. North America is the leading market for combination vaccines due to rise in demand for vaccination among adults and children. Moreover, government efforts towards the different vaccination programs especially for the children add fuel to the North America market. The market in Asia Pacific is expected to witness the strongest growth. Prevalence of various diseases such as polio, flu, and rotavirus, and government efforts toward immunization boost the growth of the market. Moreover, China is likely to dominate the human combination vaccines market in the region during the forecast period owing to a large population base and growing government support for vaccination. Europe is also a significant market for human combination vaccines due to well-developed health care infrastructure and increased spending on health. According to the World Health Organization, over 40% of children from sub-Saharan Africa have not received the required three doses of diphtheria-tetanus-pertussis vaccine and demand for vaccination is increasing to address the unmet need. These factors are likely to augment the human combination vaccines market in Middle East & Africa during the forecast period.
Major players operating in the global human combination vaccines market are GlaxoSmithKline, Merck, Sanofi, Sun Pharmaceuticals, Takeda Pharmaceutical, Bavarian Nordic, and Pfizer, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.